Imago BioSciences
+$0.10 (+0.45%) As of 2:50 PM UTC today
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell IMGO and other ETFs, options, and stocks.
About IMGO
Imago BioSciences, Inc. operates as a clinical-stage biopharmaceutical company that develops novel anti-cancer therapeutics. It translates science of genetics and epigenetics enzymes into novel medicines for treating myeloid diseases that pose challenges to patients, families, and physicians.
CEO
Hugh Young Rienhoff
Employees
14
Headquarters
South San Francisco, California
Founded
2012
IMGO Key Statistics
Market Cap
789.51M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
79.27K
High Today
$24.02
Low Today
$23.19
Open Price
$24.02
Volume
7.79K
52 Week High
$35.68
52 Week Low
$14.99
IMGO Earnings
-$8.13
-$5.42
-$2.71
$0.00
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 11, After Hours